Mirati Therapeutics Inc (NASDAQ:MRTX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MRTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MRTX

  • Market Cap$8.237bn
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS60468T1051

Company Profile

Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer.Mirati Therapeutics Inc is a biotechnology company. The company’s focuses on precision medicine for oncology therapeutics. The company provides bioavailable inhibitors with distinct target profiles aiming to treat cancer patients.

Latest MRTX news

Currently there for this company. Visit our news hub for other news .